Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 22, 2018
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mateon Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Mateon Therapeutics Inc
| 250K |
—
|
—
| +500.00% | 300K |
Apr 12
| |||||||
Mateon Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 12
| |||||||
Oxigene Inc
|
0
|
—
|
—
|
—
|
0
|
Mar 21
| |||||||
Oxigene Inc
|
0
|
—
|
—
|
—
|
0
|
Jul 20
| |||||||
Oxigene Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Transcept Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Oct 30
| |||||||
Transcept Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Transcept Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Dec 16
| |||||||
Transcept Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Neurobiological Technologies Inc /ca/
| 25K |
$0.75 | $18,750.00 |
∞
| 25K |
Oct 22
| |||||||
Neurobiological Technologies Inc /ca/
|
0
|
—
|
—
|
—
|
0
| ||||||||
Osteologix, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Genelabs Technologies Inc /ca
|
0
|
—
|
—
|
—
|
0
|
Jan 27
| |||||||
Genelabs Technologies Inc /ca
|
0
|
—
|
—
|
—
|
0
|
Dec 5
| |||||||
Genelabs Technologies Inc /ca
|
0
|
—
|
—
|
—
|
0
|
Jan 27
| |||||||
Genelabs Technologies Inc /ca
| 6.13K |
$1.28 | $7,817.03 | +9.12% | 73.37K |
Jun 30
| |||||||
Genelabs Technologies Inc /ca
|
0
|
—
|
—
|
—
|
0
|
Jan 23
| |||||||
Genelabs Technologies Inc /ca
| 7.92K |
$1.28 | $10,104.38 | +11.43% | 77.24K |
Dec 31
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||